You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tc-99m-labeled SSTR2-Antagonist

Showing 1 - 25 of 4,471
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)

Enrolling by invitation
  • Prostate Cancer
  • Whole body study and SPECT with [99mTc]Tc-BQ0413
  • Tomsk, Russian Federation
    TomskNRMC
Oct 26, 2023

Prostate Cancer, Breast Cancer Trial in Tomsk (Intravenous injection of [99mTc]Tc-DB8)

Recruiting
  • Prostate Cancer
  • Breast Cancer
  • Intravenous injection of [99mTc]Tc-DB8
  • Tomsk, Russian Federation
    TomskNRMC
Jul 4, 2023

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

Enrolling by invitation
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Olga
Jun 19, 2023

Rheumatoid Arthritis Trial in Los Angeles, Chicago, London (Tc 99m tilmanocept)

Recruiting
  • Rheumatoid Arthritis
  • Tc 99m tilmanocept
  • Los Angeles, California
  • +3 more
Sep 13, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Melanoma Trial in Lausanne (Tc-99m tilmanocept)

Recruiting
  • Melanoma
  • Tc-99m tilmanocept
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois
Jun 11, 2022

Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell

Active, not recruiting
  • Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
  • +2 more
  • Computed Tomography
  • +7 more
  • Seattle, Washington
  • +1 more
Jul 18, 2022

Thyroid Gland Diseases Trial in Edmonton (CTC, G-PERT)

Completed
  • Thyroid Gland Diseases
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Apr 1, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
  • +5 more
Feb 11, 2022

Parathyroid Adenoma, Hyperparathyroidism, F18-choline Trial in Brest, Caen, Rennes (MIBI scintigraphy, F18-choline PET)

Active, not recruiting
  • Parathyroid Adenoma
  • +2 more
  • MIBI scintigraphy
  • F18-choline PET
  • Brest, France
  • +3 more
May 6, 2022

Breast Cancer Trial in Shanghai (Injection of 99mTc-NM-02)

Unknown status
  • Breast Cancer
  • Injection of 99mTc-NM-02
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 6, 2020

NSCLC Trial in Shanghai (Injection of 99m-Tc-NM-01)

Unknown status
  • Non-Small Cell Lung Cancer
  • Injection of 99m-Tc-NM-01
  • Shanghai, China
  • +1 more
Aug 20, 2020

Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)

Suspended
  • Head and Neck Squamous Cell Carcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 16, 2021

Breast Cancer, Radiotoxicity Trial in Shanghai (Injection of 99mTc-NM-02, Injection of 188Re-NM-02)

Unknown status
  • Breast Cancer
  • Radiotoxicity
  • Injection of 99mTc-NM-02
  • Injection of 188Re-NM-02
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 14, 2020

Hemoptysis, Malignant Tumor, Lung Cancer Trial (Technicium 99 MAA infusion)

Withdrawn
  • Hemoptysis
  • +2 more
  • Technicium 99 MAA infusion
  • (no location specified)
Aug 15, 2022

CNS Tumors, CNS Tumor Trial in Saint Louis (Tc-99m tilmanocept)

Recruiting
  • Central Nervous System Neoplasms
  • Central Nervous System Tumor
  • Tc-99m tilmanocept
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Diabetic Kidney Disease Trial in San Diego (Tc-99m-Tilmanocept)

Recruiting
  • Diabetic Kidney Disease
  • Tc-99m-Tilmanocept
  • San Diego, California
    UC San Diego Medical Center
Feb 16, 2022

Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

Recruiting
  • Systemic Amyloidosis
  • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
  • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 10, 2023

Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)

Enrolling by invitation
  • Solid Tumor, Adult
  • Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
  • Tomsk, Russian Federation
    TomskNRMC
Jan 23, 2023

Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)

Recruiting
  • Carcinoma
  • +2 more
  • 99mTc-Macro Albumin Aggregate
  • Spokane, Washington
    Inland Imaging
May 4, 2023

Breast Cancer, Lymph Node Mapping, Sentinel Lymph Node Biopsy Trial in Canada, United States (IC2000 and SPY-PHI, Tc-99m

Completed
  • Breast Cancer
  • +2 more
  • IC2000 and SPY-PHI
  • Tc-99m radioactive colloid and Gamma Probe
  • Scottsdale, Arizona
  • +6 more
Aug 17, 2021

Prostate Cancer, Breast Cancer Female Trial in Tomsk (whole body study and SPECT with 99mTc-RM26)

Enrolling by invitation
  • Prostate Cancer
  • Breast Cancer Female
  • whole body study and SPECT with 99mTc-RM26
  • Tomsk, Russian Federation
    TomskNRMC
Jul 4, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single

Recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
  • +1 more
Feb 24, 2022

Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)

Not yet recruiting
  • Prostate Cancer
  • [99mTc]Tc-PSMA-T4
  • (no location specified)
Apr 26, 2023